Click here for our 2011 patent review report
Protecting and commercialising innovation, patents are of growing significance and subject to divergent and complex global regulatory systems and rapidly changing technologies. IP Australia has recognised these challenges and has undertaken an extensive round of consultations on reform, introduced expedited case management for divisional applications and developed a new test for “inventive step”. The market has also seen a substantial jump in the number of interlocutory injunction applications within the pharmaceutical and medical device sectors.
At the forefront of developments, King & Wood Mallesons has been involved in resolving patent disputes, commercialising and registering across all sectors, including significant work across life-sciences and business methods. In this work, clients have benefited from our ability to draft patents with an intimate understanding of the technology/products and our unique understanding of what is important for commercialisation. During commercialisation, clients benefit from our ability to assess and minimise patent portfolio and litigation risks, develop a stronger negotiating position and to achieve an optimal yet cost-effective outcome.
As the market becomes increasingly global, we are increasingly coordinating patent strategies in both Australia and Asia. For other jurisdictions, clients take advantage of our ability to manage their patents through our established relationships with leading US and European law firms, agents and patent attorneys.
Click here for our 2011 Patent Review report which discusses the important and interesting patent decisions of 2011. It also covers other topics of interest such as changes in patent prosecution practice and legislative reform.